Outset Medical (OM) Shareholder's Equity (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Outset Medical | 90,946.35 | -286.55 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.02% |
| Dec 31, 2025 | -10.83% |
| Sep 30, 2025 | -8.02% |
| Jun 30, 2025 | -8.88% |
| Mar 31, 2025 | 533.39% |
| Dec 31, 2024 | -43.92% |
| Sep 30, 2024 | -30.29% |
| Jun 30, 2024 | -26.40% |
| Mar 31, 2024 | -24.16% |
| Dec 31, 2023 | -19.19% |
| Sep 30, 2023 | -16.95% |
| Jun 30, 2023 | -15.34% |
| Mar 31, 2023 | -12.08% |
| Dec 31, 2022 | -11.86% |
| Sep 30, 2022 | -9.90% |
| Jun 30, 2022 | -10.33% |
| Mar 31, 2022 | -7.65% |
| Dec 31, 2021 | -8.71% |
| Sep 30, 2021 | -4.97% |
| Jun 30, 2021 | 40.61% |
| Mar 31, 2021 | -6.68% |
| Dec 31, 2020 | -7.26% |
| Sep 30, 2020 | 206.06% |
| Jun 30, 2020 | -8.34% |
| Mar 31, 2020 | 17.15% |
| Dec 31, 2019 | -5.41% |